Kevin Finney, based in Carlsbad, CA, US, is currently a Chairman and CEO at Autobahn Therapeutics, Inc., bringing experience from previous roles at Abide Therapeutics, SK BioVentures and Eirion Therapeutics. Kevin Finney holds a 1997 - 1998 Master of Business Administration in Business @ Pepperdine Graziadio Business School. With a robust skill set that includes Pharmaceutical Industry, Commercialization, Biotechnology, Biopharmaceuticals, Medical Devices and more, Kevin Finney contributes valuable insights to the industry. Kevin Finney has 3 emails and 1 mobile phone number on RocketReach.